Australia: The "likely" blood clot death has been linked to the AstraZeneca vaccine

Australia: The “likely” blood clot death has been linked to the AstraZeneca vaccine

On April 16, authorities announced the death of an Australian woman believed to be involved in the AstraZeneca vaccine COVID-19.

(Artwork: Giovanni Cancemi / Shutterstock)

According to the Australian Vaccine Safety Investigation Group (VSIG), a 48-year-old woman was admitted to the hospital with a clot and decreased blood platelets, just four days after vaccination yesterday. April 8. The woman died in the hospital.

The team of investigators concluded that the case “is likely related to the vaccination.” This group is a panel of independent experts who advise the Australian Therapeutic Products Authority, in areas such as vaccine safety, infectious disease immunity and others.

An AstraZeneca spokesperson told The Epoch Times via email: “The safety of all patients is paramount and we are working with regulators to investigate side effects, epidemiology and muscle problems. Institutions may aim to explain these extremely rare conditions. Regulatory authorities in the European Union and the UK as well as the World Health Organization (WHO) have reaffirmed that vaccines provide high levels of protection against all severity levels. of COVID-19 and these benefits continue to outweigh the risks ”.

Test results from the dead patient are still being reviewed and autopsy will begin next week.

Two other patients in Australia also experienced clotting problems after receiving the AstraZeneca vaccine. They are being treated at the hospital and are “recovering well”, according to authorities.

Currently about 885,000 doses of the AstraZeneca vaccine have been used in Australia, so officials estimate the incidence of coagulation side effects is about 1 in 295,000.

The UK Administration of Medicines and Health Products (MHRA) has concluded when looking at blood clotting cases in the UK that the risk of blood clots after vaccination is about 1 / 250,000.

Australia’s Therapeutic Products Administration is continuing to review all reports of post-vaccination blood clots in the country.

People receiving the AstraZeneca vaccine should be aware that side effects such as fever, fatigue, and headache are probable and not worrying, unless they become severe or persistent.

Rare blood clots have occurred between days 4 and 20 after vaccination and often require hospitalization because of the severity of symptoms.

People should immediately seek medical attention if they have been vaccinated and experience a severe or persistent headache or blurred vision, difficulty breathing, chest or stomach pain, or unusual bruising in the next few days. there.

Australian Prime Minister Scott Morrison said during a press conference that federal and state authorities are still investigating the said death.

“I think there is much more to be aware of and learn about, and I will also warn others to come to conclusions on this matter,” he said.

Blood clots following a patient’s AstraZeneca vaccine vaccination prompted the European Union’s health regulator to conduct a review earlier this month. The European Drug Administration (EMA) concludes that vaccines may be related to blood clots but also recommends that everyone continue to take the AstraZeneca vaccine, which affirms that the benefits of the AstraZeneca vaccine outweigh the risk, although the European Drug Administration advises AstraZeneca to refer to the rare blood clot as a possible side effect following vaccination.

According to The Epoch Times,

Phan Anh

See more:

  • Norway: Health experts recommend banning the AstraZeneca vaccine

  • Denmark becomes the first country to permanently stop using the AstraZeneca vaccine


Related Posts

Leave a Reply

Your email address will not be published. Required fields are marked *